Aiatella Oy


AIATELLA is a Helsinki-based medtech startup founded in 2022, dedicated to revolutionizing radiology through AI technology. Their solutions aim to make image analysis 100 times faster, improving speed, accuracy, and consistency in cardiovascular diagnostics. They focus on early detection and preventative care for cardiovascular diseases, developing AI-powered imaging tools and portable screening technologies to enable early diagnosis and broader access to healthcare. Their mission is to automate slow, manual processes in medical imaging, empower doctors, and support preventative and personalized medicine.

Industries

health-diagnostics
medical-device
saas-5c4e

Nr. of Employees

small (1-50)

Aiatella Oy

Helsinki, Finland


Products

Automated image measurement platform for cardiovascular imaging

Software platform that automates detection, measurement and longitudinal tracking of cardiovascular structures and vascular abnormalities from MRI, CT and ultrasound.

Portable ultrasound screening system with real-time AI analysis

Integrated portable ultrasound screening solution that provides rapid AI-driven quantification of carotid artery narrowing and produces referral-ready outputs at point-of-care.


Services

Design and execution of clinical studies and preparation for medical approval processes in multiple countries.

On-the-ground implementation of portable ultrasound screening events and pilot deployments with clinical partners to identify at-risk individuals and validate workflows.

Expertise Areas

  • Cardiovascular imaging AI
  • Automated quantitative image analysis
  • Preventative screening programme implementation
  • Clinical evaluation and trial execution for imaging tools
  • Show More (2)

Key Technologies

  • Deep learning for medical image analysis
  • Multi-modal imaging support (MRI, CT, ultrasound)
  • Automated measurement and quantification algorithms
  • Portable ultrasound screening workflows
  • Show More (2)

News & Updates

The company showcased its preventative screening technology at Slush 2024, demonstrating its potential for early detection of cardiovascular diseases.

The Finnish medtech startup secured €2 million in funding to accelerate development, conduct clinical trials, and develop ultrasound-based screening technology.

The company received a grant to support its innovative medical technology development.

The CEO was recognized as a visionary in women's health and AI innovation.

The BBC highlighted AIATELLA's potential to address gender disparities in cardiovascular health through AI technology.

Raised funds to accelerate development and scaling of AI-powered cardiovascular imaging tools.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.